Qureshi T, Melonakos T K
Department of Medicine, Mercy Memorial Hospital, Monroe, Michigan, USA.
Ann Emerg Med. 1996 Nov;28(5):552-5. doi: 10.1016/s0196-0644(96)70120-8.
We present the case of a patient in whom hypotension, sudden cardiopulmonary arrest, and coma developed after a massive dose of a seemingly harmless cathartic agent. The diagnosis of hypermagnesemia was made 9 hours after the patient's admission, when the serum magnesium concentration was 21.7 mg/dL (8.9 mmol/L). The patient's condition improved with IV calcium, saline solution infusion, and cardiorespiratory support. The elimination half-life of magnesium in this case was 27.7 hours. Few cases have been reported in which patients have survived with serum levels greater than 18 mg/dL (7.4 mmol/L). This case provides evidence that hypermagnesemia may occur in patients with normal kidney function. The diagnosis of hypermagnesemia should be considered in patients who present with symptoms of hyporeflexia, lethargy, refractory hypotension, shock, prolonged QT interval, respiratory depression, or cardiac arrest.
我们报告了一例患者,该患者在服用大剂量看似无害的泻药后出现低血压、心搏骤停和昏迷。患者入院9小时后诊断为高镁血症,当时血清镁浓度为21.7mg/dL(8.9mmol/L)。通过静脉注射钙剂、输注生理盐水溶液和心肺支持,患者病情有所改善。该病例中镁的消除半衰期为27.7小时。血清水平高于18mg/dL(7.4mmol/L)的患者存活的病例报道较少。该病例证明,肾功能正常的患者也可能发生高镁血症。对于出现反射减退、嗜睡、难治性低血压、休克、QT间期延长、呼吸抑制或心搏骤停症状的患者,应考虑高镁血症的诊断。